European Union’s wide-ranging team of doctors recently discovered dozen of antibiotic drug resistant bacteria, after which they developed an estimate of five bug types that can lead to substantial death and infection rates. The team found out that according to 2015 stats, over 6, 70,000 individuals were ill and nearly 33,110 met with death. They also revealed that this death burden was equal to cumulative death burden of HIV, tuberculosis and influenza.
As per the study, there are higher possibilities that millions of people across Australia, North America and Europe succumb to tuberculosis, staph infection, and gonorrhea to name a few, due to superbug infections in the long run. For which, countries are likely to take crucial steps for prioritizing to fight against the constant threat that is posed by the bacteria immune to several known drugs. Middle and low-income regions are witnessing increased resistance. For instance, in Russia, Brazil and Indonesia, nearly 60% bacterial infections are strongly resistant to minimum of one antibiotic.
Notable Revelations by OECD
The OECD (Organization for Economic Co-operation and Development) has declared warning of dreadful consequences for the public healthcare as well as spending, however considering circumstances are expected to arise only in cases of increased extreme hospital hygiene and elimination of usage of unnecessary antibiotics. OECD is of the point of view that by 200, there are substantial chances of death rate increasing to 2.4million due to consumption of superbugs. In addition, OECD had mentioned that superbugs treating costs would boost to approximately $3.5Billion per year in every country, inclusive of its analysis.
The OECD public health lead, Michele Cecchini, had stated recently that every country has been spending nearly 10% of healthcare budget on the treatment of AMR (antimicrobial-resistant) bugs. The notable point is that this AMR costs comparatively more than the treatment of flu, tuberculosis and HIV.
Lack of Awareness Leading to Null Effect
Lack of awareness is leading to humans consume more antibiotics per day by means of prescriptions to stave off the infections. This in turn leads to growing development of bacteria that stimulates in resisting drug effect created for killing them. However, researchers are finding out significant ways to dive out solutions to fight resistance with quicker and better testing for determining if each infection is viral. The new swab tests is expected to dent the overuse of antibiotics in the long, thereby benefitting the healthcare industry with positive growth prospects.
With soaring consumption of antibiotics across the globe, doctors are alarming over the multi drug-resistant bacteria strains. Increasing need for patient safety and burgeoning demand for the alternative treatment options is expected to create significant and immediate opportunities for the healthcare industry.